Moderna (MRNA) shares rallied on June 26 after the company detailed its future beyond COVID-19 at its highly anticipated Science Day event. Shares are continuing their upward trend today.
As investors cheered the positive updates, MRNA’s relative strength index (RSI) climbed into the early 70s, indicating the stock may now be ripe for profit-taking.